Press & News

December 06th 2017 - Press Release

Private equity firm EMERAM invests in Meona and, the innovation leaders in the field of clinical software

Munich, 23 November 2017 - Funds advised by Munich-based private equity firm EMERAM Capital Partners GmbH ("EMERAM") today announced plans to invest in Meona GmbH und bvba, with a view to creating a new innovation leader in the field of clinical software. The newly formed group will be jointly led by the current management teams of both companies under the leadership of Dr. Tobias Schäfer. All parties have agreed not to disclose financial details of the transaction.

Meona GmbH offers forward-thinking solutions for best-in-class patient care and patient management. Meona software supports the safe prescription of medicines, the efficient documentation of vital parameters, and the simple coding of diagnoses. This subsequently leads to a higher quality of medical treatment and improved patient safety. Meona is based in Freiburg, Germany. develops and implements software to support hospital treatment processes, for use predominantly in emergency rooms and operating theatres. Its primary product is ED, which manages process control in emergency rooms through intuitive treatment documentation. is based in Turnhout, Belgium, and is market leader in the DACH region.

PD Dr. med. Tobias Schäfer, Joint Managing Director and co-founder of Meona GmbH, said: "Meona has been the leading brand for safety and expertise in healthcare IT since 2008. Our partnership with, a specialist in emergency room software, will strengthen and complement our joint product portfolio. In EMERAM, we have found a partner with the expertise and long-term focus to support us as we take the next steps in our growth."

Dr. med. Matthias Wuttke, Joint Managing Director and co-founder of Meona GmbH, added: "By using innovative technologies and leveraging our deep understanding of patient care processes, we have developed a software solution that flexibly meets our clients' requirements in their entirety. In recent years we have delivered the concept of 'a paperless hospital'. EMERAM will now enable us to create a new platform together with and other partners which will offer best-in-class solutions from one source."

Kris Dens, CEO of bvba, said: "At, our technical expertise and consulting services allow us to provide seamless solutions to over 100 emergency rooms and operating theatres across Europe. We look forward to exploring further international growth opportunities with our new partners Meona and EMERAM."

The current management of both Meona and will remain in their positions, and will work with key individuals from across both organisations to shape the overall management on the holding company level.

Dr. Christian Näther, founding partner of EMERAM Capital Partners, said: "The software developed by both Meona GmbH and bbva makes important contributions to the optimisation of processes in the healthcare sector. Our commitment to both companies will create a strong platform for building a digital innovation leader in the field of clinical software."

EMERAM Capital Partners was advised by Jones Day (Legal), Roever Broenner Susat Mazars (Finance & Tax), Codex Partners (Commercial), Raiffeisenlandesbank NÖ-Wien (Financing) and Willis Towers Watson (Insurance).

FGvW (Freiburg) advised the partners of Meona GmbH in this transaction. Dr. Hendrik Thies (Corporate / M&A), Dr. Frank Jungfleisch (M&A / IT, both in lead), Dr. Morton Douglas (IP), Dr. Stefan Lammel (M&A / Corporate Finance), and Dr. Oliver Wasmeier (M&A / Corporate Finance) were involved. Tax advice was provided by StB / WP Martin Klumpp of Trewitax.

Grant Thornton (Antwerpen) advised bvba in this transaction. Marc Van den Bossche (Partner Tax & Legal), Tim Dausy (Senior Manager Legal) and Valérie Rivière (Senior Manager Business Process Solutions) were involved.